JACOBSON PHARMA CORPORATION LIMITED CONTENTS
2
Corporate Information
3
Financial Highlights
4
Corporate Vision and Mission
5
Corporate Profile
6
Management Discussion and Analysis
17
Other Information
23
Review Report to the Board of Directors
24
Unaudited Consolidated Statement of Profit or Loss and Other Comprehensive Income
26
Unaudited Consolidated Statement of Financial Position
27
Unaudited Consolidated Statement of Changes in Equity
28
Unaudited Condensed Consolidated Cash Flow Statement
29
Notes to the Unaudited Interim Financial Report
43
Glossary
CORPORATE INFORMATION
BOARD OF DIRECTORS
Executive Directors
Mr. Sum Kwong Yip, Derek
(Chairman and Chief Executive Officer)
Mr. Yim Chun Leung
Ms. Pun Yue Wai
Independent Non-executive Directors
Dr. Lam Kwing Tong, Alan
Mr. Young Chun Man, Kenneth
Professor Wong Chi Kei, Ian
Professor Lam Sing Kwong, Simon
(re-designated from non-executive Director to independent non-executive Director with effect from 1 November 2021)
AUDIT COMMITTEE
Mr. Young Chun Man, Kenneth (Chairman) Dr. Lam Kwing Tong, Alan Professor Wong Chi Kei, Ian Professor Lam Sing Kwong, Simon
REMUNERATION COMMITTEE
Dr. Lam Kwing Tong, Alan (Chairman)
Mr. Young Chun Man, Kenneth
Ms. Pun Yue Wai
NOMINATION COMMITTEE
Professor Wong Chi Kei, Ian (Chairman)
Dr. Lam Kwing Tong, Alan
Mr. Young Chun Man, Kenneth
Mr. Yim Chun Leung
AUTHORISED REPRESENTATIVES
Mr. Yim Chun Leung
Ms. Pun Yue Wai
COMPANY SECRETARY
Mr. Yu Chun Kau
REGISTERED OFFICE
Cricket Square
Hutchins Drive
PO Box 2681
Grand Cayman KY1-1111
Cayman Islands
HONG KONG HEADQUARTERS AND PRINCIPAL PLACE OF BUSINESS
Unit 2313-18, 23/F
Tower 1, Millennium City 1
388 Kwun Tong Road
Kwun Tong, Kowloon
Hong Kong
PRINCIPAL SHARE REGISTRAR AND TRANSFER OFFICE
Conyers Trust Company (Cayman) Limited
Cricket Square
Hutchins Drive
PO Box 2681
Grand Cayman KY1-1111
Cayman Islands
HONG KONG BRANCH SHARE REGISTRAR
Tricor Investor Services Limited
Level 54, Hopewell Centre
183 Queen's Road East
Hong Kong
AUDITOR
KPMG
Certified Public Accountant Public Interest Entity Auditor registered in accordance with the Financial Reporting Council Ordinance
PRINCIPAL BANKERS
(in alphabetical order) Chong Hing Bank Limited
Standard Chartered Bank (Hong Kong) Limited
The Hongkong and Shanghai Banking
Corporation Limited
PUBLIC RELATIONS CONSULTANT
Strategic Public Relations Group
INVESTOR RELATIONS
Email: jacobsonpharma@sprg.com.hk
STOCK CODE
2633
COMPANY WEBSITE
www.jacobsonpharma.com
003
FINANCIAL HIGHLIGHTS
Six months ended | Six months ended | ||
30 September 2021 | 30 September 2020 | Change | |
HK$'000 | HK$'000 | ||
Revenue (Restated)(1) | |||
- Generic drugs | 562,177 | 503,795 | +11.6% |
- Branded healthcare | 188,236 | 191,630 | -1.8% |
Total | 750,413 | 695,425 | +7.9% |
Gross profit | 272,842 | 266,257 | +2.5% |
Gross profit margin (%) | 36.4% | 38.3% | |
Profit attributable to equity shareholders of the Company | 80,039 | 102,513 | -21.9% |
Profit margin attributable to equity shareholders of the Company (%) | 10.7% | 14.7% | |
Adjusted EBITDA(2) | 203,856 | 233,391 | -12.7% |
Adjusted EBITDA margin (%)(3) | 27.2% | 33.6% | |
Return on equity (%)(4) | 5.8% | 8.4% | |
As at | As at | ||
30 September 2021 | 31 March 2021 | Change | |
HK$'000 | HK$'000 | ||
Total assets | 4,838,009 | 4,867,150 | -0.6% |
Total liabilities | 1,931,556 | 2,007,041 | -3.8% |
Total equity | 2,906,453 | 2,860,109 | +1.6% |
- During the year ended 31 March 2021, the Group completed the spin-off listing of its branded healthcare business, which comprised branded medicines, proprietary Chinese medicines and health and wellness products. For the purpose of segment reporting, the Group reviewed the reportable segments and identified branded healthcare as a reportable segment for the year ended 31 March 2021 and for the six months ended 30 September 2021. The segment information for the six months ended 30 September 2020 for comparative purpose has been restated.
- Adjusted EBITDA is calculated based on adjusted earnings before interest, taxes, depreciation and amortisation, where "interest" is regarded as including interest income and interest expenses and "depreciation and amortisation" is regarded as including impairment losses on non- current assets. To arrive at adjusted EBITDA, the Group's earnings are further adjusted for share of losses of associates, share of losses of joint ventures and non-recurring items not attributable to the operations of individual segments.
- Adjusted EBITDA margin is calculated based on adjusted EBITDA divided by revenue and multiplied by 100%.
- Return on equity is calculated based on annualised profit for the period divided by the arithmetic mean of the opening and closing balances of total equity in the relevant period and multiplied by 100%.
Creating | |
JACOBSON PHARMA CORPORATION LIMITED | INTERIM REPORT 2021 | Values |
004
CORPORATE VISION AND MISSION
A MISSION | A VISION | A CULTURE |
THAT | THAT | THAT |
MATTERS | INSPIRES | ACHIEVES |
OUR VISION
At Jacobson, we aspire to be an eminent player in essential medicines and consumer healthcare solutions in Asia.
OUR CULTURE
Three core components i.e. Challenge, Connect, Commit unite our corporate culture and values that define how we act and what we do:
OUR MISSION
We strive to create sustainable values that meet current and future customer needs through carefully-orchestrated investment in R&D.
We enhance the communities in which we operate.
We build shareholder values in all we do.
Challenge
We proactively venture into uncharted turf for exploring opportunities. We go the extra-mile for attaining excellence via innovative solutions.
Connect
We work cohesively as one company one team to create and share best practices. We connect local knowledge with global resources.
Commit
We deliver on what we promise. We do not compromise on quality and integrity.
JACOBSON PHARMA CORPORATION LIMITED
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Jacobson Pharma Corporation Ltd. published this content on 10 December 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 16 December 2021 11:18:03 UTC.
